Cambridge, MA, United States of America

Mark Rogge

This inventor holds 4 USPTO granted patents and 2 published patent applications. Top assignees: Vima Therapeutics, Inc., Takeda Pharmaceutical Company Limited. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark Rogge. Retrieved from https://idiyas.com/inventor/mark-rogge-f2n9lkm7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 75.0

Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2025-2026

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Mark Rogge - Innovator in Therapeutic Methods for Movement Disorders

Introduction

Mark Rogge is an accomplished inventor based in Sorrento, FL (US). He has made significant contributions to the field of therapeutic methods aimed at treating movement disorders. His innovative approach combines various pharmacological agents to enhance treatment efficacy and patient outcomes.

Latest Patents

Mark Rogge holds 1 patent for his invention titled "Therapeutic methods and compositions for treating movement disorders." This patent outlines a method that utilizes a muscarinic acetylcholine receptor inhibitor in conjunction with a muscarinic acetylcholine receptor activator. The goal is to effectively treat conditions such as dystonia while minimizing side effects associated with the inhibitor.

Career Highlights

Throughout his career, Mark has focused on developing novel therapeutic strategies that address complex movement disorders. His work has been instrumental in advancing the understanding of how specific receptor interactions can lead to improved treatment protocols.

Collaborations

Mark has collaborated with notable professionals in the field, including Judith Dunn and Bernard Mayer Ravina. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Mark Rogge's contributions to the field of movement disorder treatments exemplify the impact of innovative thinking in medicine. His patent reflects a commitment to improving patient care through scientific advancement.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…